Antony Riley Biography and Net Worth

Chief Financial Officer of Forte Biosciences

Mr. Riley has served as Forte’s Chief Financial Officer since March 2020. Prior to joining Forte, Mr. Riley was at Krystal Biotech, Inc., a biotechnology company, from September 2017 to February 2020 where he was the Chief Financial Officer. Previously, Mr. Riley was a founding partner since 2002 of the CFO Network LLC, a consulting firm and was Acting Chief Financial Officer at Avanex Corporation and Corporate Controller at Kosan Biosciences. He also served in numerous capacities at Troy Chemical Corporation from 1997 to 2000. Mr. Riley received a B.Sc. (Honors) from the University of Bristol (England) and an M.B.A. (Honors) from the University of Chicago, Booth School of Business. Mr. Riley is a CPA (inactive) in the state of California.

What is Antony A. Riley's net worth?: The estimated net worth of Antony A. Riley is at least $1.01 million as of November 21st, 2024. Mr. Riley owns 30,776 shares of Forte Biosciences stock worth more than $1,010,684 as of April 22nd. This net worth approximation does not reflect any other investments that Mr. Riley may own. Learn More about Antony A. Riley's net worth.
How do I contact Antony A. Riley?: The corporate mailing address for Mr. Riley and other Forte Biosciences executives is 1124 W CARSON STREET MRL BUILDING 3-320, TORRANCE CA, 90502. Forte Biosciences can also be reached via phone at (310) 618-6994 and via email at [email protected]. Learn More on Antony A. Riley's contact information.
Has Antony A. Riley been buying or selling shares of Forte Biosciences?: Antony A. Riley has not been actively trading shares of Forte Biosciences during the last ninety days. Most recently, on Thursday, November 21st, Antony A. Riley bought 22,514 shares of Forte Biosciences stock. The stock was acquired at an average cost of $5.55 per share, with a total value of $124,952.70. Following the completion of the transaction, the chief financial officer now directly owns 30,776 shares of the company's stock, valued at $170,806.80. Learn More on Antony A. Riley's trading history.
Who are Forte Biosciences' active insiders?: Forte Biosciences' insider roster includes Antony Riley (Chief Financial Officer), and Paul Wagner (Insider). Learn More on Forte Biosciences' active insiders.

Antony A. Riley Insider Trading History at Forte Biosciences

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
11/21/2024	Buy	22,514	$5.55	$124,952.70	30,776

Antony A. Riley Buying and Selling Activity at Forte Biosciences

Forte Biosciences Company Overview

Forte Biosciences, Inc. operates as a biopharmaceutical company in the United States. The company is developing FB-102 program that addresses various autoimmune diseases, such as graft-versus-host disease, and vitiligo and alopecia areata. Forte Biosciences, Inc. is headquartered in Dallas, Texas.

Today's Range

Now: $31.58

$31.00

$33.33

50 Day Range

MA: $28.74

$23.50

$35.09

2 Week Range

Now: $31.58

$4.90

$35.80

Volume

31,136 shs

Average Volume

269,788 shs

Market Capitalization

$438.65 million

P/E Ratio

N/A

Dividend Yield